B. Braun

B. Braun of America Appoints Two Executive Leadership Team Members to its Board of Directors

Retrieved on: 
Friday, March 1, 2024
Senior, Mentorship, Multimedia, B. Braun, Patient, Management

BETHLEHEM, Pa., March 1, 2024 /PRNewswire/ -- B. Braun of America Inc. today announced the appointment of two members of its Executive Leadership Team to the company's Board of Directors. Rob Albert, who was recently announced as the next Chief Executive Officer of B. Braun of America Inc., and Leigh Ann Stradford, Senior Vice President and Chief Human Resources Officer of B. Braun Medical Inc., each bring a diverse set of experience and leadership in the healthcare industry to the Board.

Key Points: 
  • BETHLEHEM, Pa., March 1, 2024 /PRNewswire/ -- B. Braun of America Inc. today announced the appointment of two members of its Executive Leadership Team to the company's Board of Directors.
  • "I am proud to welcome Rob and Leigh Ann to B. Braun of America's Board," said Jean-Claude Dubacher, Chairman and Chief Executive Officer.
  • "It is an honor to join the B. Braun of America Board of Directors as we work to transform the future of our organization," said Stradford.
  • The addition of Rob Albert and Leigh Ann Stradford follows the previously announced appointments of Dr. Dorothee Bartels and Michael Reitermann to the B. Braun of America Board of Directors.

Rob Albert appointed Chief Executive Officer of B. Braun of America Inc.

Retrieved on: 
Wednesday, January 24, 2024
Community college, Patient, Northampton Community College, Business administration, Investment, B. Braun, PennWest Clarion, Marketing

BETHLEHEM, Pa., Jan. 24, 2024 /PRNewswire/ -- The Board of Directors of B. Braun of America Inc. ("B. Braun of America") announced today that they have appointed Rob Albert as Chief Executive Officer of B. Braun of America, succeeding Jean-Claude Dubacher who is taking on global management responsibilities, while remaining Chairman of the Board of B. Braun of America. Albert's appointment will be effective April 1, 2024.

Key Points: 
  • He will assume responsibility for B. Braun of America and all its subsidiaries in North America
    BETHLEHEM, Pa., Jan. 24, 2024 /PRNewswire/ -- The Board of Directors of B. Braun of America Inc. ("B. Braun of America") announced today that they have appointed Rob Albert as Chief Executive Officer of B. Braun of America, succeeding Jean-Claude Dubacher who is taking on global management responsibilities, while remaining Chairman of the Board of B. Braun of America.
  • He has served as Senior Vice President & Chief Marketing Officer of B. Braun of America's subsidiary, B. Braun Medical Inc., since 2012.
  • "I am humbled and grateful for the opportunity to lead B. Braun of America and continue the transformation journey we began three years ago," said Albert.
  • "As I assume my new global role in the B. Braun organization, I could not be more confident that we have selected the right person to lead B. Braun of America," said Dubacher.

Europe Syringes & Needles Insights Report 2023: A $7.97 Billion Market in 2022 - Forecasts to 2028 with BD, CardinalHealth, B Braun, Nipro, and Terumo Dominating - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 13, 2023
Medical Supplies, Health, Syringe, Research, Conditional sentence, Incidence, Element, B. Braun, Lead, Growth, Hospital, Diabetes, Video game, Needle

The "Europe Syringes & Needles Market - Focused Insights 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Syringes & Needles Market - Focused Insights 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • This comprehensive report delves into the intricacies of the syringes and needles market in Europe, covering the period from 2023 to 2028.
  • It provides an extensive overview of various factors that are propelling the market growth, alongside potential restraints and emerging trends.
  • Key players like BD, CardinalHealth, B Braun, Nipro, and Terumo Corp are at the forefront of the European syringes & needles market.

Rockwell Medical Announces 3-Year Co-Promotional Collaboration with B. Braun Medical

Retrieved on: 
Thursday, June 29, 2023
Medical Devices, Trucking, Medical Supplies, Packaging, Transport, Professional Services, Small Business, Manufacturing, Health, Logistics, Supply Chain Management, Dialysis, Sale, Automatic activation device, Rockwell Medical, The Company, Senior, Patient, B. Braun, Pharmaceutical industry, Marketing

As part of the agreement, Rockwell Medical designates B. Braun as an independent, non-exclusive representative to promote the Company's hemodialysis concentrates products to dialysis providers in the United States, concertedly on the west coast.

Key Points: 
  • As part of the agreement, Rockwell Medical designates B. Braun as an independent, non-exclusive representative to promote the Company's hemodialysis concentrates products to dialysis providers in the United States, concertedly on the west coast.
  • All terms of the sale of any Rockwell Medical product, including price, delivery schedule, and terms and conditions, are set by Rockwell Medical, at the Company's sole discretion.
  • "This co-marketing and sales arrangement with B. Braun represents a significant commercial opportunity for Rockwell Medical that immediately connects us to a new customer base we wouldn't be able to reach otherwise," said Tim Chole , Senior Vice President, Sales and Marketing at Rockwell Medical.
  • “We are pleased to align with Rockwell Medical to promote their hemodialysis concentrate products,” said Jonathan Stapley, Senior Director of Marketing, Active Devices at B. Braun.

B. Braun Partners with Cognite to Power Its Data-First Transformation

Retrieved on: 
Tuesday, January 17, 2023
Technology, Packaging, Engineering, Chemicals, Plastics, Automotive Manufacturing, Utilities, Manufacturing, Coal, Nuclear, Energy, Software, Networks, Internet, Data Management, B. Braun, DevOps, Knowledge, EHS, Maintenance, Partnership, Operational technology, Intuition, Television, Online shopping, Risk management, Cognitive computing

Cognite , a global leader in industrial software, today announced B. Braun, a leading medical technology company, has selected Cognite Data Fusion ® as the core of its Manufacturing Data Management solution.

Key Points: 
  • Cognite , a global leader in industrial software, today announced B. Braun, a leading medical technology company, has selected Cognite Data Fusion ® as the core of its Manufacturing Data Management solution.
  • The Manufacturing Data Management solution will provide a fully digital DevOps workflow to develop, deploy, and sustain a pipeline of business applications.
  • "On behalf of Cognite, we are proud to partner with B. Braun as they transform into a data-first organization based on a strong operational data foundation.
  • As part of the partnership, Cognite will collaborate with B. Braun to integrate its in-house support tools with Cognite’s user community, Cognite Hub , to provide seamless support to the B. Braun organization.

Aesculap, Inc. Partners with QMed Innovations, Inc. to Offer Surgical Instrument Tray Asset Management and Delivery Solution

Retrieved on: 
Monday, December 19, 2022
Organization, General surgery, Partnership, Neurosurgery, B. Braun, Gold, Quest, Temperature, Intelligence, Machine learning, Medical device, Asclepius

MIDDLETOWN, R.I., Dec. 19, 2022 /PRNewswire/ -- QMed Innovations, innovating IoT-powered solutions for global asset management of surgical trays and implant inventory, has announced its partnership with Aesculap, Inc., the market leader in sterile container systems1. The QMed Innovations' Quest sensor, designed to withstand autoclave temperatures, can now be attached to the AESCULAP Aicon™ Sterile Container System to collect valuable, actionable data such as tray turns and tray inventory. This combination offers customers a seamless inventory management experience to help increase efficiencies, reduce costs and ensure compliance with sterile processing guidelines.

Key Points: 
  • This combination offers customers a seamless inventory management experience to help increase efficiencies, reduce costs and ensure compliance with sterile processing guidelines.
  • The QMed Innovations' Quest sensor attaches to the bracket at either end of the AESCULAP Aicon™ container.
  • The QVue portal offers insights that can help customers:
    "The partnership with Aesculap provides medical device OEMs the latest in autonomous cellular IoT-based asset management and sterile container system delivery solutions.
  • QMed helps reduce healthcare costs throughout the value stream via automated delivery of data and analytics for unparalleled insight.

B. Braun Will Showcase its APEX® Compounding System with Clinical Decision Support Order Entry Software at the ASHP Midyear Meeting and Exhibition

Retrieved on: 
Thursday, December 1, 2022
TPN, Pharmacy, Insulin, Safety, Patient safety, Mandalay Bay Convention Center, Health, Communication, Patient satisfaction, Parenteral nutrition, Pharmacist, Patient, Multimedia, ASHP, B. Braun, Risk, APEX, Pitt, Television, Pharmaceutical industry, Medical device

TPN Manager software incorporates Trissel's Ca/P check to help minimize the risk of precipitation and allows users to create templates to standardize their order format.

Key Points: 
  • TPN Manager software incorporates Trissel's Ca/P check to help minimize the risk of precipitation and allows users to create templates to standardize their order format.
  • Also featured are dosing limits to alert and prevent prescribers from ordering doses of ingredients that exceed recommended or safe clinical limits.
  • The order then automatically routes to the APEX compounder without the need for transcription.
  • The APEX Compounding System was specifically designed to address the immediate needs of critically ill patients from neonates to adults while also meeting the critical needs of pharmacists.

B. Braun's Space® Infusion Pump Systems Earn UL 2900-2-1 Certification

Retrieved on: 
Thursday, December 1, 2022
Software, Stapley, Space, Communication, B. Braun, Organization, Food, Health care, Multimedia, Part, Risk, Certification, Hospital, Patient safety, Health, CAP, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Caregiver, Government, ANSI, Spacecom, EMR, Patient satisfaction, Marketing, Senior, Safety, UL, Pain management, Wireless, American National Standards Institute, FDA, Medical device

BETHLEHEM, Pa., Dec. 1, 2022 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, today announced that the wireless devices of the Space Infusion Pump System* earned certification to UL 2900-2-1** through UL Cybersecurity Assurance Program (UL CAP). The UL 2900-2-1 standard is published as a U.S. national consensus standard by the American National Standards Institute (ANSI) and a recognized consensus standard by the U.S. Food and Drug Administration (FDA) supporting their pre- and post-market cybersecurity guidance.

Key Points: 
  • BETHLEHEM, Pa., Dec. 1, 2022 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, today announced that the wireless devices of the Space Infusion Pump System* earned certification to UL 2900-2-1** through UL Cybersecurity Assurance Program (UL CAP).
  • The technical experts at UL Solutions explored all facets of the UL 2900-2-1 Standard requirements in their evaluation of the Space Infusion Pump Systems for CAP certification.
  • In addition to receiving certification to the UL 2900-2-1 Standard, Perfusor Syringe Pump,within B. Braun's Space Infusion Pump Systems platform, is the first in the industry with medical ground and/or air transport in the FDA cleared indications for use.
  • * Space Infusion Pump System includes the Wireless Infusomat 8713051U, SpaceStation with SpaceCom 8713142U, and Perfusor 8713031U.

MindClick Moderates Webinar on ESG and Supply Chain Management Featuring Speakers from Atrium Health, B. Braun Medical, and Vizient

Retrieved on: 
Wednesday, November 9, 2022
GLOBE, Office of Inspector General, U.S. Department of Health and Human Services, Carbon, ESG, Leadership, Intelligence, GHG, Sustainability, Knowledge, Social responsibility, Risk, Organization, U.S. Department of Defense Strategy for Operating in Cyberspace, Low-carbon economy, Atrium Health, Federal Ministry for Climate Action, Environment, Energy, Mobility, Innovation and Technology, Goal, SVP, Environment, B. Braun, Supply chain, Time-invariant system, CEO, DEI, Modern Healthcare, Hospital, Management, Renewable energy, Food industry, Risk management, Vizient, Inc.

Speakers discuss the power of data, and changes in operating practices in each of their organizations to improve overall transparency of the supply chain in support of resiliency and ESG leadership.

Key Points: 
  • Speakers discuss the power of data, and changes in operating practices in each of their organizations to improve overall transparency of the supply chain in support of resiliency and ESG leadership.
  • The healthcare industry is the 12th largest contributor to global GHG emissions, with over 70 percent due to the supply chain.
  • Conrad Emmerich , SVP of Supply Chain, Lab, Imaging & chief procurement officer at Atrium Health.
  • As Modern Healthcares most trusted ESG advisor, MindClick is uniquely qualified to spearhead the advancement of a sustainable and resilient supply chain for the healthcare industry.

Global Renal Osteodystrophy Market Research Report 2022-2028 Featuring Major Players - Amgen, Asahi Kasei, and B. Braun Medical, Baxter International, & DaVita - ResearchAndMarkets.com

Retrieved on: 
Friday, October 28, 2022
Health, General Health, Baxter International, AstraZeneca, Prevalence, Renal osteodystrophy, Cancer, Growth, Government, Adoption, PKD, Goodpasture syndrome, Syringe, Patient, Chronic kidney disease-mineral and bone disorder, Ajinomoto, Chronic kidney disease, Dapagliflozin, Parathyroidectomy, Amgen, Ageing, Alport syndrome, Research, List, Philippine Council of Evangelical Churches, WHO, Incidence, Kidney transplantation, Hypertension, Atherosclerosis, B. Braun, Pharmaceutical industry, Medical device, Marketing

The "Global Renal Osteodystrophy Market Research and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Renal Osteodystrophy Market Research and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.
  • The global renal osteodystrophy market is anticipated to grow at a considerable growth during the forecast period.
  • The global renal osteodystrophy market is segmented on the basis on diagnosis method, and treatment.
  • The major companies serving the global renal osteodystrophy market are Amgen Inc., Asahi Kasei Corp., and B. Braun Medical, Baxter International Inc., DaVita Inc., and others.